Vaccine leader signs deal for 1 billion Covid-19 doses a year

Moderna’s experimental shot induces the body’s own cells to make virus-like proteins that stimulate an immune response and prepare for an actual infection. It was one of the first proposed coronavirus vaccines to enter human trials. The company said it plans to begin the next phase of studies this quarter.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3aWDpgh
via IFTTT